Loading…

Mitochondrial Localization of Human PANK2 and Hypotheses of Secondary Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration

: Mutations in the pantothenate kinase 2 gene (PANK2) lead to pantothenate kinase‐associated neurodegeneration (PKAN, formerly Hallervorden‐Spatz syndrome). This neurodegenerative disorder is characterized by iron accumulation in the basal ganglia. Pantothenate kinase is the first enzyme in the bios...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the New York Academy of Sciences 2004-03, Vol.1012 (1), p.282-298
Main Authors: JOHNSON, MONIQUE A., KUO, YIEN MING, WESTAWAY, SHAWN K., PARKER, SUSAN M., CHING, KATHERINE H. L., GITSCHIER, JANE, HAYFLICK, SUSAN J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:: Mutations in the pantothenate kinase 2 gene (PANK2) lead to pantothenate kinase‐associated neurodegeneration (PKAN, formerly Hallervorden‐Spatz syndrome). This neurodegenerative disorder is characterized by iron accumulation in the basal ganglia. Pantothenate kinase is the first enzyme in the biosynthesis of coenzyme A from pantothenate (vitamin B5). PANK2, one of four human pantothenate kinase genes, is uniquely predicted to be targeted to mitochondria. We demonstrate mitochondrial localization of PANK2 and speculate on mechanisms of secondary iron accumulation in PKAN. Furthermore, PANK2 uses an unconventional translational start codon, CUG, which is polymorphic in the general population. The variant sequence, CAG (allele frequency: 0.05), leads to skipping of the mitochondrial targeting signal and cytosolic localization of PANK2. This common variant may cause mitochondrial dysfunction and impart susceptibility to late‐onset neurodegenerative disorders with brain iron accumulation, including Parkinson's disease.
ISSN:0077-8923
1749-6632
DOI:10.1196/annals.1306.023